[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Some permanent long covid", "description": "Link to free download of John\u2019s 2 textbooks.\nhttp://159.69.48.3/       (you may need to cut and paste this link into a brouser)\n\n\nProfiling post-COVID syndrome across different variants of SARS-CoV-2\n\nhttps://www.medrxiv.org/content/10.1101/2022.07.28.22278159v1\n\nAcross all variants\n\nCentral neurological cluster of symptoms\n\nCardiorespiratory cluster of symptoms\n\nDebilitating multi-organ systemic inflammatory symptoms\n\nCentral neurological cluster of symptoms\n\nAnosmia / dysosmia\n\nFatigue\n\nBrain-fog\n\nDepression\n\nDelirium\n\nHeadache\n\n(Largest cluster in both alpha and delta variants, and the second largest for the wild-type variant)\n\nConsistent UK Biobank study\n\nSARS-CoV-2 is associated with changes in brain structure in UK Biobank\n\nhttps://www.nature.com/articles/s41586-022-04569-5?feature%5Bconsent-app%5D=1&optanonConsent=15\n\nReduction in grey matter thickness\n\nTissue damage in primary olfactory cortex\n\nReduction in global brain size \n\nCardiorespiratory cluster of symptoms\n\n(Largest cluster in the wild-type period)\n\nSymptoms may reflect lung damage\n\nDyspnoea\n\nChest pain\n\nFatigue\n\nPalpitations\n\nConsistent study from Medicine\n\nClinical characteristics and outcomes of post-COVID-19 pulmonary fibrosis\n\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772621/\n\nPost-COVID-19 pulmonary fibrosis is a severe complication that leads to permanent lung damage or death.\n\nDebilitating multi-organ symptoms\n\n(Present in all variants)\n\nSystemic/inflammatory\n\nAbdominal symptoms\n\nMyalgias (muscle pain)\n\nVaccination and long covid\n\nwe did not observe evidence of qualitatively different symptom clustering in vaccinated vs. unvaccinated individuals, \n\nwith either alpha or delta variants. \n\nBackground\n\nIt is now evident that post-COVID syndrome presents with heterogeneous profiles,\n\nneed characterisation to enable personalised care\n\nMethods\n\nProspective longitudinal cohort study\n\nN = 336,652 subjects\n\n(Covid Symptom Study)\n\nTested positive\n\nLong-COVID = lasting longer than 28 days\n\nN = 1,459 with post-COVID syndrome (more than 12 weeks of symptoms)\n\nOne in 230 symptomatic, test confirmed cases\n\nClustering analysis, to identify distinct symptom profiles\n\nAcross\n\nVariants of SARS-CoV-2\n\nVaccination status at the time of infection\n\nClusters were characterised\n\nSymptom prevalence\n\nDuration\n\nDemography\n\nPrior conditions (comorbidities)\n\nFindings\n\nWe identified distinct profiles of symptoms for post-COVID syndrome\n\nWild-type variant\n\nFour endotypes identified\n\nAlpha variant\n\nSeven endotypes\n\nDelta variant\n\nFive endotypes in vaccinated subjects\n\nEndotype\n\na subtype of a disease condition, \n\ndefined by a distinct pathophysiological mechanism\n\nInterpretation \n\nOur classification may be useful to understand distinct mechanisms of the post-COVID syndrome, as well as subgroups of individuals at risk of prolonged debilitation.\n\nDr Claire Steves, clinical lead author, King's College London\n\nhttps://news.sky.com/story/three-types-of-long-covid-each-with-different-symptoms-researchers-say-12663531\n\nThese data show clearly that post-COVID syndrome is not just one condition, but appears to have at several subtypes.\n\nUnderstanding the root causes of these subtypes may help in finding treatment strategies.\n\nMoreover, these data emphasise the need for long COVID services to incorporate a personalised approach sensitive to the issues of each individual.\n\nDr Liane Canas, author\n\nThese insights could aid in the development of personalised diagnosis and treatment for these individuals", "link": "https://www.youtube.com/watch?v=F7x5LcUaUVQ", "date_published": "2022-08-04 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]